Invention Grant
US09101117B2 SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto
有权
用于治疗胰岛素抵抗和与之相关疾病的SorCS1样试剂
- Patent Title: SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto
- Patent Title (中): 用于治疗胰岛素抵抗和与之相关疾病的SorCS1样试剂
-
Application No.: US13377277Application Date: 2010-06-10
-
Publication No.: US09101117B2Publication Date: 2015-08-11
- Inventor: Karen-Marie Pedersen , Anders Nykjaer
- Applicant: Karen-Marie Pedersen , Anders Nykjaer
- Applicant Address: DK
- Assignee: Aarhus Universitet
- Current Assignee: Aarhus Universitet
- Current Assignee Address: DK
- Agency: Sunstein Kann Murphy & Timbers LLP
- Priority: DK200970024 20090610
- International Application: PCT/DK2010/050131 WO 20100610
- International Announcement: WO2010/142266 WO 20101216
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61K38/10 ; C07K14/705 ; A01K67/027 ; A61K48/00 ; A61K38/00
Abstract:
The present invention relates to SorCS1-like agents, including SorCS1, nucleic acid molecule encoding expression of SorCS1 and fragments thereof, as well as vectors containing said nucleic acid and to cells expressing SorCS1 and said fragments, for use in the treatment of insulin resistance.
Public/Granted literature
- US20120156183A1 SORCS1-LIKE AGENT FOR USE IN THE TREATMENT OF INSULIN RESISTANCE AND DISEASES RELATED THERETO Public/Granted day:2012-06-21
Information query
IPC分类:
